10 computer-network Postdoctoral positions at The Ohio State University in United-States
-
, chemistry, electrical and computer engineering, materials science and engineering, or computer science and engineering. Desired Qualifications: Expertise applicable to quantum networking systems and devices
-
, geriatrics, and advanced liver disease. Education: We educate trainees and practicing clinicians on primary palliative care principles from multiple disciplines and subspecialities. Our program has five ACGME
-
Scholars are expected to lead analyses critical to the species delimitation research program and to take initiative in contributing to the design of investigations into little brown bats and other species
-
, agriculture-based net emissions technologies, such as uptake and storage by agricultural soils and bioenergy production, are recognized as important components of future emission pathways to limit global
-
motivated researcher with a strong background in computational modeling, system identification, and uncertainty quantification for civil infrastructure. The successful candidate will join the Risk Assessment
-
candidate will demonstrate a record of excellence in one or more core areas of quantum information, such as quantum computing, quantum algorithms, quantum simulation, quantum networks, or quantum sensing
-
, and therapeutic response and resistance and to translate these findings to improve patient outcomes. The overall goal of this research program—spanning basic mechanistic discoveries, application of high
-
of this research program—spanning basic mechanistic discoveries, application of high-throughput technologies, validation in cancer-relevant mouse models, and translation platforms—is to understand the fundamental
-
member of the Oncology Research Information Exchange Network (ORIEN) Robust clinical trials program with active translational therapeutics that include a clinical research unit, Phase 1 U01 grant and N01
-
) Founding member of the Oncology Research Information Exchange Network (ORIEN) Robust clinical trials program with active translational therapeutics that include a clinical research unit, Phase 1 U01 grant